KALA MATHEW: Open Payments
NPI 1295412146 · MERRICK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$806 in 31 payments from 19 companies in 2025. Trend: 2023 $14 · 2024 $0 · 2025 $806
Food & beverage: $707Education: $99
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 4 | $186 |
| Merck Sharp & Dohme LLC | 3 | $96 |
| GENZYME CORPORATION | 2 | $54 |
| Janssen Biotech, Inc. | 2 | $52 |
| Novartis Pharmaceuticals Corporation | 3 | $49 |
| TerSera Therapeutics LLC | 2 | $49 |
| Stemline Therapeutics Inc. | 2 | $44 |
| Iovance Biotherapeutics, Inc. | 1 | $35 |
| PharmaEssentia USA Corporation | 2 | $30 |
| Lilly USA, LLC | 1 | $27 |
Products named: Enhertu, KEYTRUDA, SARCLISA, Zoladex, Orserdu, Amtagvi, KISQALI, BESREMI.
Industry payments across NY — which companies pay providers there.
